Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
How our clients use DrugPatentWatch
To get paragraph IV challenges, detailed regulatory status and tentative approvals
— Dosage form R&D services company, India
For a comprehensive list of patents, along with their details, for some drug molecules
— Business analyst, India
To be aware of drugs likely to come off patent soon to help budget
— Hospital pharmacist, UK
To gather valuable information on past, current, and future/prospective diabetes products
— Pharmacist, Luxembourg
Patent expiration dates for current drugs on market, especially drugs that target the Central Nervous System.
— Business development for a clinical trial research site, USA
To research if drugs are still protected with patents or not
— Investment Analyst, France
To see which patents for drugs are expiring to do pipeline planning for our company
— Business development manager, South Africa
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 087068
is a drug marketed by Leading Pharma Llc, Watson Labs, Roxane, Ivax Sub Teva Pharms, Prinston Inc, Actavis Elizabeth, Impax Labs, Ipca Labs Ltd, Unichem, Jubilant Cadista, Whiteworth Town Plsn, Sun Pharm Inds Inc, Vangard, Mylan, Sandoz, Sciegen Pharms Inc, Aurolife Pharma Llc, Solvay, Teva, Lannett, Superpharm, Usl Pharma, Heather, Mylan Pharms Inc, Ascot, Alembic Pharms Ltd, Elkins Sinn, Alra, Accord Hlthcare, Dava Pharms Inc, Morton Grove, Lannett Holdings Inc, Aurobindo Pharma, Tg United Labs, Inwood Labs, Barr, Abc Holding, Sun Pharm Inds, Apotex, Hikma Intl Pharms, Heritage Pharms Inc, Warner Chilcott, Mast Mm, Pvt Form, West Ward, and Pharmeral, and is included in one hundred and nine NDAs. It is available from seventy-four suppliers. Additional details are available on the HYDROCHLOROTHIAZIDE profile page.
The generic ingredient in HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Suppliers and Packaging for NDA: 087068
National Drug Code
30 TABLET in 1 BOTTLE (64205-821-30)
Summary for product number 001
Active Rx/OTC/Discontinued: RX Dosage: TABLET;ORAL Strength 50MG Approval Date: Approved Prior to Jan 1, 1982 TE: AB RLD: No Complete Access Available with
How our clients use DrugPatentWatch
To know the expiration date of patents of international companies, which sell drugs in Russia
— Analyst, Russia
To find out about drugs in current trials and when they come off patent for horizon scanning of likely changes to treatment pathways in the UK
— Charity, UK
To stay up to speed on latest developments
— VP product development, USA
For patent explorations of some brand products
— Pharma advertising, Russia
To study patents on drugs in selected therapeutic areas
— Pharmaceutical process development, India
To track filing and history of various APIs
— API research and development, USA
To explore which pharmaceutical products are still under patent protection
— Managing partner for pharmaceutical company, Lebanon
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Related Products from thinkBiotech